BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15800033)

  • 1. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity.
    Boverhof DR; Burgoon LD; Tashiro C; Chittim B; Harkema JR; Jump DB; Zacharewski TR
    Toxicol Sci; 2005 Jun; 85(2):1048-63. PubMed ID: 15800033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice.
    Boverhof DR; Burgoon LD; Tashiro C; Sharratt B; Chittim B; Harkema JR; Mendrick DL; Zacharewski TR
    Toxicol Sci; 2006 Dec; 94(2):398-416. PubMed ID: 16960034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicogenomic examination of the hepatic effects of PCB126 and TCDD in immature, ovariectomized C57BL/6 mice.
    Kopec AK; Boverhof DR; Burgoon LD; Ibrahim-Aibo D; Harkema JR; Tashiro C; Chittim B; Zacharewski TR
    Toxicol Sci; 2008 Mar; 102(1):61-75. PubMed ID: 18042819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
    Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
    Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative temporal toxicogenomic analysis of TCDD- and TCDF-mediated hepatic effects in immature female C57BL/6 mice.
    N'Jai A; Boverhof DR; Dere E; Burgoon LD; Tan YS; Rowlands JC; Budinsky RA; Stebbins KE; Zacharewski TR
    Toxicol Sci; 2008 Jun; 103(2):285-97. PubMed ID: 18343893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice.
    Kopec AK; Burgoon LD; Ibrahim-Aibo D; Burg AR; Lee AW; Tashiro C; Potter D; Sharratt B; Harkema JR; Rowlands JC; Budinsky RA; Zacharewski TR
    Toxicol Sci; 2010 Nov; 118(1):286-97. PubMed ID: 20702594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis.
    Angrish MM; Jones AD; Harkema JR; Zacharewski TR
    Toxicol Sci; 2011 Dec; 124(2):299-310. PubMed ID: 21890736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands.
    Kopec AK; Burgoon LD; Ibrahim-Aibo D; Mets BD; Tashiro C; Potter D; Sharratt B; Harkema JR; Zacharewski TR
    Toxicol Appl Pharmacol; 2010 Mar; 243(3):359-71. PubMed ID: 20005886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated dose-response analysis of the relative hepatic gene expression potency of TCDF in C57BL/6 mice.
    Burgoon LD; Ding Q; N'jai A; Dere E; Burg AR; Rowlands JC; Budinsky RA; Stebbins KE; Zacharewski TR
    Toxicol Sci; 2009 Nov; 112(1):221-8. PubMed ID: 19675144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin.
    Pierre S; Chevallier A; Teixeira-Clerc F; Ambolet-Camoit A; Bui LC; Bats AS; Fournet JC; Fernandez-Salguero P; Aggerbeck M; Lotersztajn S; Barouki R; Coumoul X
    Toxicol Sci; 2014 Jan; 137(1):114-24. PubMed ID: 24154488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-Dependent Metabolic Reprogramming and Differential Gene Expression in TCDD-Elicited Hepatic Fibrosis.
    Nault R; Fader KA; Ammendolia DA; Dornbos P; Potter D; Sharratt B; Kumagai K; Harkema JR; Lunt SY; Matthews J; Zacharewski T
    Toxicol Sci; 2016 Dec; 154(2):253-266. PubMed ID: 27562557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
    Nault R; Fader KA; Lydic TA; Zacharewski TR
    Chem Res Toxicol; 2017 Apr; 30(4):1060-1075. PubMed ID: 28238261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.
    Fader KA; Nault R; Kirby MP; Markous G; Matthews J; Zacharewski TR
    Toxicol Appl Pharmacol; 2017 Apr; 321():1-17. PubMed ID: 28213091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in gene expression and benzo[a]pyrene-induced DNA adduct formation in the liver of three strains of female mice with identical AhRb2 genotype treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin and/or benzo[a]pyrene.
    Wu Q; Suzuki JS; Zaha H; Lin TM; Peterson RE; Tohyama C; Ohsako S
    J Appl Toxicol; 2008 Aug; 28(6):724-33. PubMed ID: 18172886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice.
    Kopec AK; D'Souza ML; Mets BD; Burgoon LD; Reese SE; Archer KJ; Potter D; Tashiro C; Sharratt B; Harkema JR; Zacharewski TR
    Toxicol Appl Pharmacol; 2011 Oct; 256(2):154-67. PubMed ID: 21851831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin.
    Nault R; Fader KA; Kirby MP; Ahmed S; Matthews J; Jones AD; Lunt SY; Zacharewski TR
    Toxicol Sci; 2016 Feb; 149(2):358-71. PubMed ID: 26582802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCDD-elicited effects on liver, serum, and adipose lipid composition in C57BL/6 mice.
    Angrish MM; Dominici CY; Zacharewski TR
    Toxicol Sci; 2013 Jan; 131(1):108-15. PubMed ID: 22977169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats.
    Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT
    Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice.
    Fader KA; Nault R; Ammendolia DA; Harkema JR; Williams KJ; Crawford RB; Kaminski NE; Potter D; Sharratt B; Zacharewski TR
    Toxicol Sci; 2015 Dec; 148(2):567-80. PubMed ID: 26377647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic exposure of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces an obesogenic effect in C57BL/6J mice fed a high fat diet.
    Brulport A; Le Corre L; Chagnon MC
    Toxicology; 2017 Sep; 390():43-52. PubMed ID: 28774668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.